Edgestream Partners L.P. lowered its position in shares of Chemed Co. (NYSE:CHE – Free Report) by 51.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,007 shares of the company’s stock after selling 5,404 shares during the quarter. Edgestream Partners L.P.’s holdings in Chemed were worth $2,653,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of CHE. UMB Bank n.a. boosted its position in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares during the last quarter. Trust Co. of Vermont bought a new stake in Chemed during the fourth quarter valued at $34,000. SRS Capital Advisors Inc. boosted its position in Chemed by 39.2% during the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company’s stock valued at $72,000 after acquiring an additional 38 shares during the last quarter. Allworth Financial LP boosted its position in Chemed by 2,057.1% during the fourth quarter. Allworth Financial LP now owns 151 shares of the company’s stock valued at $83,000 after acquiring an additional 144 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its position in Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after acquiring an additional 324 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.
Insider Transactions at Chemed
In related news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction dated Monday, December 30th. The shares were bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on CHE
Chemed Price Performance
CHE stock opened at $595.86 on Monday. The stock has a market capitalization of $8.72 billion, a PE ratio of 30.11, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. The company’s 50-day moving average is $553.87 and its 200-day moving average is $563.91. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62.
Chemed Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- Dividend Payout Ratio Calculator
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Investing In Preferred Stock vs. Common Stock
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.